Fixed- versus variable-dose prothrombin complex concentrate protocol for vitamin K antagonist reversal
Volume: 114, Issue: 3, Pages: 334 - 341
Published: Jun 30, 2021
Abstract
Fixed-dose prothrombin complex concentrates (PCCs) for the reversal of vitamin K antagonists may decrease the incidence of thromboembolic events, treatment costs, and treatment delays. However, the ideal fixed dose is unknown, with some studies showing inadequate reversal with suboptimal dosing or in patients with a higher international normalized ratio (INR) or weight. This indicates a need for a modified fixed-dose strategy that considers...
Paper Details
Title
Fixed- versus variable-dose prothrombin complex concentrate protocol for vitamin K antagonist reversal
Published Date
Jun 30, 2021
Volume
114
Issue
3
Pages
334 - 341
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History